A higher-dose regimen of nusinersen, currently up for approval in the U.S., may provide further benefits to people with…
Articles by Andrea Lobo
Treatment with Evrysdi (risdiplam) is generally safe and effective at improving or stabilizing motor and lung function in adults…
Interim results from a Phase 1 clinical trial show salanersen, Biogen’s treatment candidate for spinal muscular atrophy (SMA),…
The case of a woman with spinal muscular atrophy (SMA) type 2 who developed an abnormal accumulation of molecules…
Training with a wearable robotic device called HAL, for hybrid assistive limb, improved walking ability for people with spinal…
SMA Europe will host its 1st International Clinical Care Symposium on SMA and focus on the biological causes…
Treatment with Spinraza (nusinersen) and physical therapy that focused on posture improved motor skills in a young boy with…
Most adolescents and adults with spinal muscular atrophy (SMA) have normal sensory nerve function, even those with long-lasting disease,…
Poor sleep is associated with more severe depressive symptoms and respiratory issues in adults with spinal muscular atrophy (SMA),…
Newborn screening (NBS) programs for spinal muscular atrophy (SMA) were available in 33 countries as of the beginning of…